Literature DB >> 27291777

Clinical characteristics of aquagenic pruritus in patients with myeloproliferative neoplasms.

C Le Gall-Ianotto1,2, E Brenaut2, M Gouillou3, K Lacut3, E Nowak3, A Tempescul4, C Berthou4, V Ugo5, J L Carré1,6, L Misery1,2, J C Ianotto3,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27291777     DOI： 10.1111/bjd.14809

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  3 in total

Review 1.  A guideline for the management of specific situations in polycythaemia vera and secondary erythrocytosis: A British Society for Haematology Guideline.

Authors:  Mary F F McMullin; Adam J Mead; Sahra Ali; Catherine Cargo; Frederick Chen; Joanne Ewing; Mamta Garg; Anna Godfrey; Steven Knapper; Donal P McLornan; Jyoti Nangalia; Mallika Sekhar; Frances Wadelin; Claire N Harrison
Journal:  Br J Haematol       Date:  2018-11-13       Impact factor: 6.998

2.  Rationale and design of the multicentric, double-blind, double-placebo, randomized trial APrepitant versus HYdroxyzine in association with cytoreductive treatments for patients with myeloproliferative neoplasia suffering from Persistent Aquagenic Pruritus. Trial acronym: APHYPAP.

Authors:  C Le Gall-Ianotto; R Verdet; E Nowak; L Le Roux; A Gasse; A Fiedler; D Carlhant-Kowalski; P Marcorelles; L Misery; J C Ianotto
Journal:  Trials       Date:  2021-12-19       Impact factor: 2.279

3.  Prevalence and Clinical Characteristics of Aquagenic Pruritus among Medical and Pharmacy Students in Lomé (Togo).

Authors:  Julienne Noude Teclessou; Koussake Kombate; Abla Sefako Akakpo; Abas Mouhari-Toure; Julie Zoua; Panawe Kassang; Bayaki Saka; Palokinam Pitche
Journal:  Dermatol Res Pract       Date:  2020-05-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.